About the program
The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center. The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a national center to: 1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.
Who can apply
Any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. 5304 (formerly cited as 25 U.S.C. 450b)) is eligible to apply. See 42 CFR § 51a.3(a)). Domestic faith-based and community-based organizations are eligible to apply.
Contact us
Cristina Novoa, Ph.D.
(301) 443-1463
Grants toolbox
Manage your grant
Contact us
Contact HRSA
1-877-464-4772
(TTY: 877-897-9910)
M - F | 8 a.m. - 8 p.m.
(except holidays)
Contact grants.gov
Call 800-518-4726
Email grants.gov support
Report fraud
Submit a Complaint
Call: 1-800-HHS TIPS
(1-800-447-8477)
(TTY: 1-800-377-4950)